ArticleBMC cancer2019
Interleukin-6 mediates resistance to PI3K-pathway-targeted therapy in lymphoma.
Joo Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this papertrialcites it
ArticleBMC cancer2019
Joo Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.